Study: Drinking coffee cuts risk of liver problems
Coffee drinkers, fill up that mug.
A new study published on Monday in the journal BMC Public Health found that drinking up to three or four cups of coffee — caffeinated or decaffeinated — a day cuts the risk of developing and dying from chronic liver diseases, CNN reports.
For the study, researchers followed 494,585 participants for nearly 12 years. They determined that coffee drinkers were 21 percent less likely to develop chronic liver disease, 20 percent less likely to develop chronic or fatty liver disease, and 49 percent less likely to die from chronic liver disease than those who do not drink coffee. The researchers found that the most benefit came from drinking ground (as opposed to instant) caffeinated or decaf coffee. Most coffee studies are based on 8-ounce cups of black coffee, CNN cautions.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Coffee is widely accessible, and the benefits we see from our study may mean it could offer a potential preventative treatment for chronic liver disease," study author Dr. Oliver Kennedy of Britain's University of Southampton said in a statement. "This would be especially valuable in countries with lower income and worse access to health care and where the burden of chronic liver disease is highest."
The American Liver Foundation says that over the last two decades, the number of people diagnosed with nonalcoholic fatty liver disease has more than doubled, and the American Cancer Society found that between 1980 and 2021, the rate of liver cancer more than tripled with death rates doubled.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Israel jolted by ‘shocking’ settler violenceIN THE SPOTLIGHT A wave of brazen attacks on Palestinian communities in the West Bank has prompted a rare public outcry from Israeli officials
-
Magazine printables - November 14, 2025Puzzles and Quizzes Issue - November 21, 2025
-
The Week contest: French cyclist rescuedPuzzles and Quizzes
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
